/pictures/brand%2Ffondatioun%2Fpoldi-runs.jpg)
by Anna Weber
Cette année, je participe à la course solidaire LËTZ GO GOLD, organisée par la Fondatioun Kriibskrank Kanner, pour collecter des fonds en faveur de la recherche sur les cancers pédiatriques : découvrir de nouveaux traitements, améliorer ceux existants et mieux comprendre les causes de ces cancers chez les enfants.
Chaque participant s'engage à collecter un minimum de 200 €.
Si vous souhaitez soutenir la fondation dans cette lutte contre le cancer, je vous invite à faire un don. 👇🏼
Merci d'avance pour votre soutien ! 🧡🦁
#lëtzgogold2024 #fightchildhoodcancer
This year, I am participating in the LËTZ GO GOLD charity run, organized by the Fondatioun Kriibskrank Kanner, to raise funds for pediatric cancer research: to discover new treatments, improve existing ones, and better understand the causes of childhood cancers.
Each participant commits to raising a minimum of €200.
If you would like to support the foundation in this fight against cancer, please consider making a donation. 👇🏼
Thank you in advance for your support! 🧡🦁
#lëtzgogold2024 #fightchildhoodcancer
— Anna
LËTZ GO GOLD is a charity run organised by the Fondatioun Kriibskrank Kanner and takes place on the last Saturday morning of September. Each participant agrees to collect a minimum of € 200 (€ 100 for minors and students under 25 years of age) to fund paediatric cancer research: find new cures, improve existing ones, and learn more about the causes of paediatric cancers.
For the past 35 years, Fondatioun Kriibskrank Kanner has been accompanying families of children with cancer or a rare life-threatening disease on a daily basis. It’s multi-disciplinary team offers an individual accompaniment from the diagnosis to the remission of the child and offering administrative and financial services, psychological and social support and educational and recreational activities. In addition, the Foundation undertakes awareness campaigns and contributes to the improvement of the condition of the sick child. Finally, we actively support onco-pediatric research with one goal: to treat better and more.